- Home
- PWR vs HLN Comparison
PWR vs HLN Comparison
Compare PWR & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PWR
- HLN
- Stock Information
- Founded
- PWR 1997
- HLN 2022
- Country
- PWR United States
- HLN United Kingdom
- Employees
- PWR N/A
- HLN N/A
- Industry
- PWR Engineering & Construction
- HLN Package Goods/Cosmetics
- Sector
- PWR Industrials
- HLN Consumer Discretionary
- Exchange
- PWR Nasdaq
- HLN Nasdaq
- Market Cap
- PWR 56.7B
- HLN 48.2B
- IPO Year
- PWR 1998
- HLN N/A
- Fundamental
- Price
- PWR $389.52
- HLN $9.85
- Analyst Decision
- PWR Buy
- HLN Buy
- Analyst Count
- PWR 22
- HLN 1
- Target Price
- PWR $391.16
- HLN $10.95
- AVG Volume (30 Days)
- PWR 869.1K
- HLN 8.1M
- Earning Date
- PWR 10-30-2025
- HLN 07-31-2025
- Dividend Yield
- PWR 0.10%
- HLN 1.82%
- EPS Growth
- PWR 21.63
- HLN 41.64
- EPS
- PWR 6.44
- HLN 0.23
- Revenue
- PWR $26,052,930,000.00
- HLN $15,096,588,575.00
- Revenue This Year
- PWR $18.05
- HLN $1.38
- Revenue Next Year
- PWR $12.09
- HLN $4.24
- P/E Ratio
- PWR $60.48
- HLN $43.22
- Revenue Growth
- PWR 18.26
- HLN N/A
- 52 Week Low
- PWR $227.08
- HLN $8.86
- 52 Week High
- PWR $424.94
- HLN $11.42
- Technical
- Relative Strength Index (RSI)
- PWR 56.98
- HLN 53.87
- Support Level
- PWR $370.27
- HLN $9.77
- Resistance Level
- PWR $400.87
- HLN $9.93
- Average True Range (ATR)
- PWR 8.20
- HLN 0.12
- MACD
- PWR 1.61
- HLN 0.02
- Stochastic Oscillator
- PWR 70.01
- HLN 72.84
About PWR Quanta Services Inc.
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two segments: electric infrastructure and underground utility and infrastructure.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.